Arrowroot Family Office »

Arrowhead Pharmaceuticals shares owned by Arrowroot Family Office

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Arrowroot Family Office from 13F filings

Historical chart of Arrowroot Family Office investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Arrowroot Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Arrowroot Family Office

Quarter filed Position value Share count Share price at filing
2025-09-30 $390k 11k 34.49
2025-06-30 $179k 11k 15.80
2023-06-30 $232k 6.5k 35.66

More positions owned by Arrowroot Family Office

Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p Mcp Etf (IJH)
Ea Series Trust Marketdesk Focus (FDIV)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Invesco Qqq Tr Unit Ser 1
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ssga Active Tr Spdr Dbleln Shrt (STOT)

View all positions for Arrowroot Family Office

Top funds holding Arrowhead Pharmaceuticals

BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
FMR
Slate Path Capital
Geode Capital Management
Siren
Driehaus Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Ubs Global Asset Management Americas
Morgan Stanley
Baker Bros. Advisors
Marshall Wace

View all funds holding Arrowhead Pharmaceuticals